Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmonoatomic ion channel activity

LRRC8B PIEZO2

1.71e-0245992GO:0005216
GeneOntologyCellularComponentplasma membrane bounded cell projection cytoplasm

OPA1 DNAH10 IFT140

2.71e-0431793GO:0032838
GeneOntologyCellularComponentcytoplasmic region

OPA1 DNAH10 IFT140

3.94e-0436093GO:0099568
GeneOntologyCellularComponentaxoneme

DNAH10 IFT140

3.36e-0320792GO:0005930
GeneOntologyCellularComponentciliary plasm

DNAH10 IFT140

3.39e-0320892GO:0097014
HumanPhenoAbnormal visual electrophysiology

OPA1 ELOVL4 CYP4V2 PIEZO2 IFT140

8.05e-0627275HP:0030453
MousePhenoshort retina rod cell outer segment

ELOVL4 CYP4V2

2.23e-051382MP:0014336
MousePhenoabnormal retina rod cell outer segment morphology

ELOVL4 CYP4V2

1.24e-043082MP:0008456
MousePhenoabnormal retina inner plexiform layer morphology

OPA1 CYP4V2

1.50e-043382MP:0003734
DomainTPR

DNAH10 IFT140

2.68e-0316592PS50005
DomainTPR_REGION

DNAH10 IFT140

2.68e-0316592PS50293
Pubmed

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.

DNAH10 PDE3B

1.25e-05219222479202
Pubmed

Nonsyndromic Retinitis Pigmentosa Overview

CYP4V2 IFT140

1.91e-04819220301590
InteractionSLC8A3 interactions

PDE3B GPD2

2.40e-051792int:SLC8A3
InteractionSLC39A4 interactions

ELOVL4 PDE3B GPD2

4.21e-0516393int:SLC39A4
InteractionLRRC8B interactions

LRRC8B PDE3B

9.29e-053392int:LRRC8B
CoexpressionGSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN

PDE3B CYP4V2 GPD2 IFT140

3.94e-0719994M4331
CoexpressionZHENG_FOXP3_TARGETS_DN

PDE3B GPD2

1.57e-06692M1754
CoexpressionZHENG_FOXP3_TARGETS_DN

PDE3B GPD2

2.20e-06792MM734
CoexpressionGSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN

CYP4V2 GPD2 IFT140

3.55e-0520093M7833
ToppCellfacs-Lung-Endomucin-24m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OPA1 PDE3B

2.23e-041139291e73e3b93be242fef0f14eddd8085a1f1c730ef
ToppCellfacs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OPA1 PDE3B

2.23e-0411392357bc20edc5bc14eab8262d52260ed1686e9dc54
ToppCelldroplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE3B IFT140

2.81e-0412792983489a69d3b1f1fe21110a862ac1dba53e9d31c
ToppCellMild/Remission-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

DNAH10 GPD2

3.13e-04134925bd1e3fa6278facd9e949e9e5e244e700190126b
ToppCell356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ELOVL4 IFT140

3.22e-0413692edfd453c9a650d69d05a5a3ab15f7df56349fa86
ToppCell356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ELOVL4 IFT140

3.22e-041369203e4e2353c23ceffde35b2d0aadd15299e3db09f
ToppCellMild/Remission-B_intermediate-14|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

DNAH10 GPD2

3.46e-041419269e32125a0e8f0c8561e5e7a93607f368f09546f
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PDE3B PIEZO2

4.45e-04160920293b244c063a62819690bf22bbc2681f8d15252
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PDE3B PIEZO2

4.45e-04160923eaae86fa08f7651021316f8e5811bf48055591e
ToppCell390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells)

ELOVL4 PDE3B

4.68e-0416492b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f
ToppCell343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells)

LRRC8B PDE3B

4.79e-0416692a54377c703efff42d2cc1a8fdb610facc58053dd
ToppCell10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue

LRRC8B PDE3B

4.79e-04166929afa33b5ad27dc33576be592f9b22d8161366838
ToppCell390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells)

ELOVL4 PDE3B

4.90e-04168922781dd6b369427a94c5059b44b4c8f023f5f2988
ToppCell356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CYP4V2 IFT140

4.96e-0416992fec669968a77060bd77ee8695034e35a642c984f
ToppCell356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CYP4V2 IFT140

4.96e-04169920425d2580ed325178f522c0093ff4623de6ce7a8
ToppCellmetastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass

ELOVL4 GPD2

5.08e-04171920d14bc9688c427ba2265984987dc3eea195b19eb
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ELOVL4 DNAH10

5.20e-041739266f37c1437705734b20601656fa4aa1d92ca30be
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ELOVL4 DNAH10

5.20e-0417392649b08a409095592cccf31883be69c754411280d
ToppCellAdult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor

ELOVL4 PIEZO2

5.32e-04175924db1a3c284488b3f6de7568363f176d74e2a4587
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PIEZO2

5.32e-0417592f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69
ToppCellAdult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor

ELOVL4 PIEZO2

5.32e-04175928d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell5'-Adult-LargeIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ELOVL4 PDE3B

5.50e-0417892f52f837e948deb6a2d031325f49891bca8d375da
ToppCelldroplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PIEZO2

5.81e-0418392f55081068213cc1cdb2acad58ff10f6b48b44c72
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PIEZO2

5.88e-0418492ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

DNAH10 GPD2

5.88e-041849284c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DNAH10 GPD2

5.88e-0418492a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DNAH10 GPD2

5.88e-0418492081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCellControl-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class

DNAH10 GPD2

5.88e-041849245f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PIEZO2

5.88e-04184922cbed6462fea2622871bb7e49b0df3d984239281
ToppCellControl-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients

DNAH10 PDE3B

5.88e-0418492ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PIEZO2

5.88e-04184922b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DNAH10 GPD2

5.88e-0418492d31d4116d1d196633784863781fa45673607a421
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ELOVL4 LRRC8B

5.94e-0418592e34473eea3a58c041183a4f52137366cd9489495
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ELOVL4 PDE3B

6.00e-0418692927723ad579bbd9947ff525bd501e222d3fa9289
ToppCellNS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ELOVL4 PDE3B

6.07e-0418792fcc32dbc9c5ae6176f154715a3e73aa32d78ad64
ToppCell343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells)

LRRC8B PDE3B

6.13e-04188928f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCellRA-11._Adipocyte|World / Chamber and Cluster_Paper

LRRC8B PDE3B

6.13e-04188924dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

LRRC8B PDE3B

6.20e-0418992c26428871dc3261327d89cacaba6e21e004ff1f3
ToppCellfacs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRC8B PIEZO2

6.20e-041899209dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

PDE3B PIEZO2

6.26e-041909271e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCellPCW_13-14|World / Celltypes from embryonic and fetal-stage human lung

PDE3B PIEZO2

6.26e-041909262a3ec1ae0829602b0569cc051210551644f1d46
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9

LRRC8B GPD2

6.39e-04192924e689bca7a242f8482e25f273656e2caba8821c0
ToppCell343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

LRRC8B PDE3B

6.39e-0419292445985fe1bcd33e4f0a1704b27988fbfc9334538
ToppCellCOPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

PDE3B PIEZO2

6.39e-041929262904f94dfce430456f05066522cbf9bd29f4d7e
ToppCellControl-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PDE3B PIEZO2

6.46e-0419392e1d546165dcc2392f540162206852c4717d7306f
ToppCellControl-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

PDE3B PIEZO2

6.46e-04193925896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

LRRC8B PDE3B

6.46e-0419392abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellfacs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRC8B PIEZO2

6.53e-0419492f159ef8541d75a4e98468947f231bb463bec922c
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PDE3B PIEZO2

6.53e-0419492011e14d9ed1393275f892060e7708ffadcd0767f
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

PDE3B PIEZO2

6.53e-0419492b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCellChildren_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

PDE3B GPD2

6.59e-04195929d649ac7d2af313481069c95349efc0c68449e2b
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

PDE3B PIEZO2

6.59e-04195920e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellremission-CD4+_Tcm|World / disease stage, cell group and cell class

ELOVL4 PDE3B

6.59e-0419592365a06e2fb48ec5262a4e2580ba5a592e48127e0
ToppCellmedial-Hematologic-CD8+_Memory/Effector_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ELOVL4 PDE3B

6.66e-0419692caef28955269f4f6fb323a74b6b73cff8db11272
ToppCellBronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LRRC8B PIEZO2

6.66e-0419692efeb272bc9e37e60d15d056b7574991c5c7501bc
ToppCellfacs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PIEZO2

6.66e-04196926bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCellControl-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients

DNAH10 GPD2

6.66e-0419692b8b7b54ca17a08fa775507bb22b1c7248ada8f40
ToppCellhealthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

ELOVL4 PDE3B

6.66e-04196926eabbac1625f715531bae562a28da27664572600
ToppCell367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PDE3B PIEZO2

6.66e-04196926730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCellmedial-Hematologic-CD8+_Memory/Effector_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ELOVL4 PDE3B

6.66e-0419692252e15a4ea54d872c5b910711941dcdf359c0492
ToppCellmedial-2-Hematologic-CD8+_Memory/Effector_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ELOVL4 PDE3B

6.66e-0419692e401d1683a13f2636e8fc0e22428a6a3653a1521
ToppCell367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PDE3B PIEZO2

6.66e-041969221dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCellfacs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PIEZO2

6.66e-0419692c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCellIPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

PDE3B PIEZO2

6.73e-0419792f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PDE3B IFT140

6.87e-0419992dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ELOVL4 PDE3B

6.87e-0419992036776a03fdd181e51cc655ed99331eec9c63f39
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ELOVL4 DNAH10

6.93e-0420092da12821e8a0657869ca0f75d351cce2d7605a505
ToppCellControl-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class

DNAH10 GPD2

6.93e-0420092118321ac443feb42aee171baccfc4610f00a8822
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type.

DNAH10 PDE3B

6.93e-04200926b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type.

DNAH10 PDE3B

6.93e-0420092be83f442179ba4217d12f0458059586ff3130991
ToppCellLPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ELOVL4 DNAH10

6.93e-042009272c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ComputationalGenes in the cancer module 205.

OPA1 GPD2

4.64e-0330542MODULE_205
DrugFenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A

ELOVL4 PDE3B GPD2

5.00e-05195937432_DN
DrugHydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A

ELOVL4 PDE3B GPD2

5.00e-05195932283_DN
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A

LRRC8B GPD2 IFT140

5.00e-05195934117_DN
DrugClorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A

ELOVL4 LRRC8B GPD2

5.00e-05195932884_DN
DrugFlurbiprofen [5104-49-4]; Down 200; 16.4uM; PC3; HT_HG-U133A

ELOVL4 LRRC8B IFT140

5.16e-05197934674_DN
DrugProbenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A

ELOVL4 PDE3B GPD2

5.16e-05197934771_DN
DrugTelenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A

ELOVL4 GPD2 IFT140

5.16e-05197937419_UP
DrugPantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A

ELOVL4 LRRC8B PDE3B

5.24e-05198933248_UP
DrugN-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A

ELOVL4 PDE3B GPD2

5.24e-05198935683_DN
Drug2-phosphoglycerate

OPA1 GPD2

5.96e-049492CID000000059
DrugNSC638615

OPA1 PDE3B

7.71e-0410792CID000097535
Drugfluorescein

OPA1 ELOVL4

1.65e-0315792CID000016850
DrugP-NE

PDE3B GPD2

1.91e-0316992CID000446755
DrugEmetine dihydrochloride [316-42-7]; Down 200; 7.2uM; MCF7; HT_HG-U133A

OPA1 GPD2

2.09e-03177924827_DN
DrugCephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; PC3; HT_HG-U133A

OPA1 GPD2

2.13e-03179924651_DN
Drugtroglitazone; Up 200; 10uM; PC3; HT_HG-U133A

ELOVL4 GPD2

2.13e-03179924456_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ELOVL4 IFT140

2.16e-03180923510_UP
DrugRolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A

PDE3B GPD2

2.28e-03185923369_DN
DrugMometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A

PDE3B GPD2

2.33e-03187922896_DN
DrugNaftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A

PIEZO2 IFT140

2.40e-03190922911_UP
DrugLY 294002; Up 200; 10uM; PC3; HT_HG-U133A

PDE3B IFT140

2.42e-03191924451_UP
DrugOxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A

LRRC8B PDE3B

2.42e-03191924124_DN
DrugPrednisolone [50-24-8]; Up 200; 11uM; HL60; HT_HG-U133A

LRRC8B PDE3B

2.42e-03191922393_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

ELOVL4 PDE3B

2.42e-03191924302_UP
DrugFludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A

LRRC8B GPD2

2.45e-03192924342_DN
DiseaseDisorder of eye

OPA1 ELOVL4 CYP4V2

2.98e-0521293C0015397
DiseaseRetinitis Pigmentosa

CYP4V2 IFT140

4.36e-0410492C0035334
Diseaseadiponectin measurement

DNAH10 PDE3B

8.56e-0414692EFO_0004502

Protein segments in the cluster

PeptideGeneStartEntry
MLPVYKWWQLPYYWV

GPD2

161

P43304
PWIQKYLWWKRYLTM

ELOVL4

206

Q9GZR5
QMILWDWDLKQWYKP

PDE3B

326

Q13370
KPWWDVFWYYITLIM

LRRC8B

21

Q6P9F7
MVGPDWKKRWLYWKN

OPA1

766

O60313
FRRIKMPWLWLDLWY

CYP4V2

231

Q6ZWL3
MPWLWLDLWYLMFKE

CYP4V2

236

Q6ZWL3
LMKYLQKWKRYRPLW

DNAH10

986

Q8IVF4
KMKDKTLWRWWAQYL

IFT140

951

Q96RY7
YEWWRKILKYFWMSV

PIEZO2

726

Q9H5I5